CHLORAPREP ONE-STEP FREPP Drug Patent Profile
✉ Email this page to a colleague
When do Chloraprep One-step Frepp patents expire, and when can generic versions of Chloraprep One-step Frepp launch?
Chloraprep One-step Frepp is a drug marketed by Becton Dickinson Co and is included in one NDA.
The generic ingredient in CHLORAPREP ONE-STEP FREPP is chlorhexidine gluconate; isopropyl alcohol. There are fifty-eight drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the chlorhexidine gluconate; isopropyl alcohol profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for CHLORAPREP ONE-STEP FREPP?
- What are the global sales for CHLORAPREP ONE-STEP FREPP?
- What is Average Wholesale Price for CHLORAPREP ONE-STEP FREPP?
Summary for CHLORAPREP ONE-STEP FREPP
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| Clinical Trials: | 46 |
| DailyMed Link: | CHLORAPREP ONE-STEP FREPP at DailyMed |
Recent Clinical Trials for CHLORAPREP ONE-STEP FREPP
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Washington | NA |
| Yaneve Fonge | Phase 4 |
| Rush University Medical Center | N/A |
Pharmacology for CHLORAPREP ONE-STEP FREPP
| Physiological Effect | Decreased Cell Wall Integrity |
US Patents and Regulatory Information for CHLORAPREP ONE-STEP FREPP
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Becton Dickinson Co | CHLORAPREP ONE-STEP FREPP | chlorhexidine gluconate; isopropyl alcohol | SPONGE;TOPICAL | 020832-003 | Apr 26, 2002 | OTC | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for CHLORAPREP ONE-STEP FREPP
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Becton Dickinson Co | CHLORAPREP ONE-STEP FREPP | chlorhexidine gluconate; isopropyl alcohol | SPONGE;TOPICAL | 020832-003 | Apr 26, 2002 | ⤷ Start Trial | ⤷ Start Trial |
| Becton Dickinson Co | CHLORAPREP ONE-STEP FREPP | chlorhexidine gluconate; isopropyl alcohol | SPONGE;TOPICAL | 020832-003 | Apr 26, 2002 | ⤷ Start Trial | ⤷ Start Trial |
| Becton Dickinson Co | CHLORAPREP ONE-STEP FREPP | chlorhexidine gluconate; isopropyl alcohol | SPONGE;TOPICAL | 020832-003 | Apr 26, 2002 | ⤷ Start Trial | ⤷ Start Trial |
| Becton Dickinson Co | CHLORAPREP ONE-STEP FREPP | chlorhexidine gluconate; isopropyl alcohol | SPONGE;TOPICAL | 020832-003 | Apr 26, 2002 | ⤷ Start Trial | ⤷ Start Trial |
| Becton Dickinson Co | CHLORAPREP ONE-STEP FREPP | chlorhexidine gluconate; isopropyl alcohol | SPONGE;TOPICAL | 020832-003 | Apr 26, 2002 | ⤷ Start Trial | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for CHLORAPREP ONE-STEP FREPP
See the table below for patents covering CHLORAPREP ONE-STEP FREPP around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| Austria | 202686 | ⤷ Start Trial | |
| Australia | 4249296 | ⤷ Start Trial | |
| Australia | 695218 | ⤷ Start Trial | |
| Canada | 2228942 | APPLICATEUR DE LIQUIDE (LIQUID APPLICATOR) | ⤷ Start Trial |
| Germany | 69521631 | ⤷ Start Trial | |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2026 - 2027
NCE-1 Patent Challenge Dates 2026 - 2027
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch